Cary J. Claiborne - 19 Sep 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role: Chief Executive Officer, Director
Signature: /s/ Cary J. Claiborne
Issuer symbol: ADIL
Transactions as of: 19 Sep 2022
Net transactions value: +$42,250
Form type: 4
Filing time: 20 Sep 2022, 19:11:07 UTC
Previous filing: 22 Aug 2022
Next filing: 25 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADIL	Common Stock	Award	$10,735	+25,000	+2.5%	$0.4294	1,025,000	19 Sep 2022	Direct	F1
transaction	ADIL	Common Stock	Award	$31,515	+75,000	+7.3%	$0.4202	1,100,000	20 Sep 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4196 through $0.4573, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2	The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4079 through $0.4230, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4196 through $0.4573, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4079 through $0.4230, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.